Cargando…
Enhanced Activity of NLRP3 Inflammasome in the Lung of Patients with Anti-Synthetase Syndrome
Anti-synthetase syndrome (ASSD) is an autoimmune disorder characterized by inflammatory interstitial lung disease (ILD). The main objective of this work was to quantify the concentrations of cytokines and molecules associated with inflammasome activation in bronchoalveolar lavage (BAL) of patients w...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818379/ https://www.ncbi.nlm.nih.gov/pubmed/36611853 http://dx.doi.org/10.3390/cells12010060 |
_version_ | 1784864971336712192 |
---|---|
author | Ramos-Martinez, Espiridión Vega-Sánchez, Angel E. Pérez-Rubio, Gloria Mejia, Mayra Buendía-Roldán, Ivette González-Pérez, Montserrat I. Mateos-Toledo, Heidegger N. Andrade, Warrison A. Falfán-Valencia, Ramcés Rojas-Serrano, Jorge |
author_facet | Ramos-Martinez, Espiridión Vega-Sánchez, Angel E. Pérez-Rubio, Gloria Mejia, Mayra Buendía-Roldán, Ivette González-Pérez, Montserrat I. Mateos-Toledo, Heidegger N. Andrade, Warrison A. Falfán-Valencia, Ramcés Rojas-Serrano, Jorge |
author_sort | Ramos-Martinez, Espiridión |
collection | PubMed |
description | Anti-synthetase syndrome (ASSD) is an autoimmune disorder characterized by inflammatory interstitial lung disease (ILD). The main objective of this work was to quantify the concentrations of cytokines and molecules associated with inflammasome activation in bronchoalveolar lavage (BAL) of patients with ASSD and a comparison group of systemic sclerosis (SSc) patients. Cytokines and lactate dehydrogenase (LDH) were determined using the concentrated BAL protein. The activity of caspase-1 and concentration of NLRP3 with the protein purified from the cell pellet in each group of patients. We found higher caspase-1 levels in ASSD vs. SSc, 1.25 RFU vs. 0.75 RFU p = 0.003, and LDH levels at 0.15 OD vs. 0.09 OD p < 0.001. A significant difference was observed in molecules associated with inflammasome activation, IL-18: 1.42 pg/mL vs. 0.87 pg/mL p = 0.02 and IFN-γ: 0.9 pg/mL vs. 0.86 pg/mL, p = 0.01. A positive correlation was found between caspase-1 and LDH in the patients with ASSD Rho 0.58 (p = 0.008) but not in the SSc group. In patients with ASSD, greater caspase-1 and higher LDH activity were observed in BAL, suggesting cell death due to pyroptosis and activation of the inflammasome pathway. |
format | Online Article Text |
id | pubmed-9818379 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98183792023-01-07 Enhanced Activity of NLRP3 Inflammasome in the Lung of Patients with Anti-Synthetase Syndrome Ramos-Martinez, Espiridión Vega-Sánchez, Angel E. Pérez-Rubio, Gloria Mejia, Mayra Buendía-Roldán, Ivette González-Pérez, Montserrat I. Mateos-Toledo, Heidegger N. Andrade, Warrison A. Falfán-Valencia, Ramcés Rojas-Serrano, Jorge Cells Article Anti-synthetase syndrome (ASSD) is an autoimmune disorder characterized by inflammatory interstitial lung disease (ILD). The main objective of this work was to quantify the concentrations of cytokines and molecules associated with inflammasome activation in bronchoalveolar lavage (BAL) of patients with ASSD and a comparison group of systemic sclerosis (SSc) patients. Cytokines and lactate dehydrogenase (LDH) were determined using the concentrated BAL protein. The activity of caspase-1 and concentration of NLRP3 with the protein purified from the cell pellet in each group of patients. We found higher caspase-1 levels in ASSD vs. SSc, 1.25 RFU vs. 0.75 RFU p = 0.003, and LDH levels at 0.15 OD vs. 0.09 OD p < 0.001. A significant difference was observed in molecules associated with inflammasome activation, IL-18: 1.42 pg/mL vs. 0.87 pg/mL p = 0.02 and IFN-γ: 0.9 pg/mL vs. 0.86 pg/mL, p = 0.01. A positive correlation was found between caspase-1 and LDH in the patients with ASSD Rho 0.58 (p = 0.008) but not in the SSc group. In patients with ASSD, greater caspase-1 and higher LDH activity were observed in BAL, suggesting cell death due to pyroptosis and activation of the inflammasome pathway. MDPI 2022-12-23 /pmc/articles/PMC9818379/ /pubmed/36611853 http://dx.doi.org/10.3390/cells12010060 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ramos-Martinez, Espiridión Vega-Sánchez, Angel E. Pérez-Rubio, Gloria Mejia, Mayra Buendía-Roldán, Ivette González-Pérez, Montserrat I. Mateos-Toledo, Heidegger N. Andrade, Warrison A. Falfán-Valencia, Ramcés Rojas-Serrano, Jorge Enhanced Activity of NLRP3 Inflammasome in the Lung of Patients with Anti-Synthetase Syndrome |
title | Enhanced Activity of NLRP3 Inflammasome in the Lung of Patients with Anti-Synthetase Syndrome |
title_full | Enhanced Activity of NLRP3 Inflammasome in the Lung of Patients with Anti-Synthetase Syndrome |
title_fullStr | Enhanced Activity of NLRP3 Inflammasome in the Lung of Patients with Anti-Synthetase Syndrome |
title_full_unstemmed | Enhanced Activity of NLRP3 Inflammasome in the Lung of Patients with Anti-Synthetase Syndrome |
title_short | Enhanced Activity of NLRP3 Inflammasome in the Lung of Patients with Anti-Synthetase Syndrome |
title_sort | enhanced activity of nlrp3 inflammasome in the lung of patients with anti-synthetase syndrome |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818379/ https://www.ncbi.nlm.nih.gov/pubmed/36611853 http://dx.doi.org/10.3390/cells12010060 |
work_keys_str_mv | AT ramosmartinezespiridion enhancedactivityofnlrp3inflammasomeinthelungofpatientswithantisynthetasesyndrome AT vegasanchezangele enhancedactivityofnlrp3inflammasomeinthelungofpatientswithantisynthetasesyndrome AT perezrubiogloria enhancedactivityofnlrp3inflammasomeinthelungofpatientswithantisynthetasesyndrome AT mejiamayra enhancedactivityofnlrp3inflammasomeinthelungofpatientswithantisynthetasesyndrome AT buendiaroldanivette enhancedactivityofnlrp3inflammasomeinthelungofpatientswithantisynthetasesyndrome AT gonzalezperezmontserrati enhancedactivityofnlrp3inflammasomeinthelungofpatientswithantisynthetasesyndrome AT mateostoledoheideggern enhancedactivityofnlrp3inflammasomeinthelungofpatientswithantisynthetasesyndrome AT andradewarrisona enhancedactivityofnlrp3inflammasomeinthelungofpatientswithantisynthetasesyndrome AT falfanvalenciaramces enhancedactivityofnlrp3inflammasomeinthelungofpatientswithantisynthetasesyndrome AT rojasserranojorge enhancedactivityofnlrp3inflammasomeinthelungofpatientswithantisynthetasesyndrome |